Tri Locum Partners LP — 13F Holdings & Portfolio
CIK 1826434 · latest 13F-HR filed 2026-05-18
Tri Locum Partners LP manages $712.5M in 13F-reported U.S. long-equity assets across 17 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are JNJ (14.22%), ISRG (9.91%), TMO (9.13%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 6 new positions, exited 4, added to 2, and trimmed 7.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$712.5M
Long-equity book
17
Distinct positions
2026-03-31
Filed 2026-05-18
+6 / −4 / ↑2 / ↓7
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- DEXCOM INC$15.9M +56.7%
- MADRIGAL PHARMACEUTICALS INC$4.0M +7.9%
Top Trims
- AXSOME THERAPEUTICS INC.-$26.3M -71.5%
- JOHNSON & JOHNSON-$23.5M -18.8%
- UNITED THERAPEUTICS CORP DEL-$17.2M -29.2%
- TEVA PHARMACEUTICAL INDS LTD-$14.1M -31.4%
- DIANTHUS THERAPEUTICS INC-$13.4M -52.4%
New Positions
- INTUITIVE SURGICAL INC$70.6M
- THERMO FISHER SCIENTIFIC INC$65.1M
- VERTEX PHARMACEUTICALS INC$57.7M
- JAZZ PHARMACEUTICALS PLC$30.0M
- TARSUS PHARMACEUTICALS INC$17.7M
Exited Positions
- DANAHER CORPORATION$79.4M
- BOSTON SCIENTIFIC CORP$49.6M
- IONIS PHARMACEUTICALS INC$44.1M
- VERA THERAPEUTICS INC$40.8M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | JOHNSON & JOHNSON | JNJ | 478160104 | $101.3M | 14.22% | 414,503 | SH |
| 2 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $70.6M | 9.91% | 153,250 | SH |
| 3 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $65.1M | 9.13% | 132,413 | SH |
| 4 | ASCENDIS PHARMA A/S | ASND | 04351P101 | $58.4M | 8.20% | 255,332 | SH |
| 5 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $57.7M | 8.10% | 129,314 | SH |
| 6 | ELI LILLY & CO | LLY | 532457108 | $56.8M | 7.98% | 61,795 | SH |
| 7 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $54.1M | 7.59% | 103,288 | SH |
| 8 | DEXCOM INC | DXCM | 252131107 | $43.8M | 6.15% | 698,158 | SH |
| 9 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $41.7M | 5.86% | 70,370 | SH |
| 10 | NUVALENT INC | NUVL | 670703107 | $31.6M | 4.44% | 308,506 | SH |
| 11 | TEVA PHARMACEUTICAL INDS LTD | TEVA | 881624209 | $30.8M | 4.32% | 1,021,008 | SH |
| 12 | JAZZ PHARMACEUTICALS PLC | JAZZ | G50871105 | $30.0M | 4.21% | 158,663 | SH |
| 13 | ARGENX SE | ARGX | 04016X101 | $23.1M | 3.24% | 31,635 | SH |
| 14 | TARSUS PHARMACEUTICALS INC | TARS | 87650L103 | $17.7M | 2.49% | 252,588 | SH |
| 15 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $12.2M | 1.71% | 145,543 | SH |
| 16 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $10.5M | 1.47% | 62,116 | SH |
| 17 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $7.0M | 0.98% | 369,588 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-18 | $712.5M | 17 | 0001826434-26-000004 |
| 2025-12-31 | 2026-02-17 | $770.1M | 15 | 0001826434-26-000002 |
| 2025-09-30 | 2025-11-14 | $435.1M | 18 | 0001826434-25-000008 |